Results 221 to 224 of about 24,446 (224)

FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION AND FUNCTIONAL TESTING (GIFT) EXOME STUDY

, 2012
Matthew J. Price, Andrew R. Carson, Sarah S. Murray, Tierney Phillips, L Huffman Janel, Rebecca L. Tisch, Eric J. Topol, Samuel Lévy   +7 more
openalex   +1 more source

Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges

, 2012
Kerstin Knies, Beatrice Schuster, Najim Ameziane, Martin A. Rooimans, Thomas Bettecken, Johan de Winter, Detlev Schindler   +6 more
openalex   +2 more sources

Exome Sequencing Identifies A Branch Point Variant in Aarskog-Scott Syndrome

, 2012
Emmelien Aten, Yu Sun, Rowida Almomani, Gijs W.E. Santen, Tobias Messemaker, Saskia M. Maas, Martijn H. Breuning, Johan T. den Dunnen   +7 more
openalex   +1 more source

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution

International Journal of Cancer, EarlyView.
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano, Tina Keshavarzian, Nadine Biernath, Annika Fendler, Maria de Santis, Joachim Weischenfeldt, Mathieu Lupien   +6 more
wiley   +1 more source